$PFE Headlines The automaker the top performers like

New Post Public Reply Private Reply Replies (0) Message Board

Oct 1, 2014 at 1:02 PM

$PFE Headlines

The automaker the top performers like the most 46 min ago - Mark Hulbert
Do the top performers like any bond funds more than Bill Gross’ new fund? 11:30 a.m. Today - Mark Hulbert
Copycat technology is the next big thing 8:51 a.m. Sept. 29, 2014 - Marek Fuchs
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Pfizer held takeover talks with Actavis 1:32 a.m. Sept. 24, 2014 - Jonathan D. Rockoff
CF Industries rises on merger talks; AstraZeneca, AbbVie fall 3:21 p.m. Sept. 23, 2014 - Sue Chang
Actavis shares rise on report of Pfizer approach 2:49 p.m. Sept. 23, 2014 - Ciara Linnane
Burger King, AbbVie among stocks hit by new tax inversion rules 2:40 p.m. Sept. 23, 2014 - Ben Eisen
Shire, AstraZeneca fall in London after U.S. tax move 12:19 p.m. Sept. 23, 2014 - Carla Mozee
The headwinds that Facebook faces 12:52 p.m. Sept. 11, 2014 - Mark Hulbert
Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders

Portola Pharma anticoagulant antidote Phase 3 trial successful 52 min ago - Seeking Alpha
Zogenix submits sNDA for abuse deterrent Zohydro 10:37 a.m. Today - Seeking Alpha
Merrill Lynch’s Key Stock Picks for the Fourth Quarter 7:35 a.m. Today - 247WallSt.com
With Ebola Looming, When Will The Defense Department Get Around To Generex? 3:22 a.m. Today - Seeking Alpha
Doctors Net Billions From Drug Firms 7:29 p.m. Sept. 30, 2014 - The Wall Street Journal Interactive Edition
GlycoMimetics Down Due to Delay in Rivipansel Study - Analyst Blog 3:10 p.m. Sept. 30, 2014 - Zacks.com
Pfizer (PFE) Aims at Women in New Viagra Ads 10:00 a.m. Sept. 30, 2014 - InvestorPlace.com
Retirees, You CAN Count On Dividend Stocks To Deliver From Here 9:54 a.m. Sept. 30, 2014 - Seeking Alpha
Top 10 Dow Dividend Stocks For October 9:39 a.m. Sept. 30, 2014 - InvestorPlace.com
Update: AstraZeneca Moves Closer To EU Approval For Moventig 3:41 a.m. Sept. 30, 2014 - Seeking Alpha
Tax Inversions Help Push Global M&A To 7-Year High 5:33 p.m. Sept. 29, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: PFE, CELG, BIIB 4:44 p.m. Sept. 29, 2014 - TheStreet.com
Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down? 11:55 a.m. Sept. 29, 2014 - benzinga.com
Can Pfizer Grow Without A Big Acquisition? 10:55 a.m. Sept. 29, 2014 - Seeking Alpha
8 Deft Dow Dogs Denote 11% To 20% September Price Surge 7:38 a.m. Sept. 29, 2014 - Seeking Alpha
5 Great Value Funds to Buy Now 7:10 a.m. Sept. 29, 2014 - InvestorPlace.com
Retirement Strategy: The 'Buy The Dips Portfolio' Had A Blah Month, But There Are A Few New Opportunities Right Now 12:01 a.m. Sept. 29, 2014 - Seeking Alpha
'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions 2:50 a.m. Sept. 28, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - A Dreary September Update 12:01 a.m. Sept. 28, 2014 - Seeking Alpha
10 Healthcare Dogs: 12% To 35% September Upsides, 1 Runt Hits 75% 6:38 a.m. Sept. 27, 2014 - Seeking Alpha

Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance 8:00 a.m. Today - GlobeNewswire
Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher 8:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 8:00 p.m. Sept. 29, 2014 - BusinessWire - BZX
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable 3:30 p.m. Sept. 26, 2014 - BusinessWire - BZX
GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel 9:01 a.m. Sept. 26, 2014 - GlobeNewswire
Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch 7:29 a.m. Sept. 26, 2014 - GlobeNewswire
Pfizer Completes Acquisition Of InnoPharma 8:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics 8:30 a.m. Sept. 24, 2014 - PR Newswire - PRF
Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts 10:39 a.m. Sept. 23, 2014 - BusinessWire - BZX
Kim Cattrall Encourages Women to Embrace Menopause with Style 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo 9:05 a.m. Sept. 22, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX
MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson's Disease 9:07 a.m. Sept. 16, 2014 - Marketwire
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale 9:10 a.m. Sept. 12, 2014 - PR Newswire - PRF
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher 9:20 a.m. Sept. 4, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. Sept. 3, 2014 - BusinessWire - BZX
BIND Therapeutics Appoints Two New Board Members 8:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Race for Life Rescue Logs 200 Flights for Shelter Pets

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Wulcea Pioneers Safety in Smart Heated Apparel

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

BAIC FOTON Eyes Africa for Bold Expansion Moves

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Karma Automotive Debuts High-Stakes Eximius Program

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

UBCF Strikes Big in Times Square with New Billboards

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...